obesity drug
obesity drug
€50 Million Boost for GLP-1 Production in France!
BIOT
🌟 Axplora invests €50M in France! 🏗️ Boosting GLP-1 manufacturing for diabetes and obesity therapies. 💊 Next-gen production by 2026! 🚀
Evotec and Partners Pioneer Breakthrough Obesity Drugs
BIOT
✨ Evotec and partners aim to revolutionize obesity treatment with novel therapeutic targets. 🏥💊 Learn more about their collaboration!
